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Abstract
BACKGROUND: AMP-activated protein kinase (AMPK) and PGC-1α were crucial metabolism enzymes not only 
in the skeletal muscles but also in the liver. Exercise can modify metabolic enzymes to improve insulin resistance. 
AIM: The aim of this study was to analyze the expression of mRNA liver metabolic enzymes gene, that is, AMPKα1, 
AMPKα2, and PGC-1α in different types and intensities of exercise.
METHODS: Healthy male Wistar rats aged 8 weeks in 150–180 g body weight were given a combination of high 
fat diet for five weeks and low doses of streptozotocin (30 mg/kgbw and 45 mg/kgbw in 0.1 citrate buffer pH 4,5) 
to develop type 2 diabetes mellitus (T2DM) rat model. Animals then were divided into five groups: One group was 
sedentary, and four groups were forced to run on the treadmill 3 times/week, 30 min each season, for 8 weeks. 
mRNA gene expression of AMPKα1, AMPKα2, and PGC-1α was determined with real-time PCR.
RESULTS: The results showed that expression of mRNA AMPKα1 in treatment groups was elevated than control 
and the much expression was showed in continuous types. The expression of mRNA AMPKα2 and PGC-1 α was 
declined in treatment group which little expression was showed in high intensity for AMPKα2 and moderate intensity 
for PGC-1 α. Base on type and exercise intensity, mRNA AMPKα1 gene expression much in moderate continuous, 
mRNA AMPKα2 gene expression higher in high intensity, both continuous and interval training, whereas mRNA 
PGC-1α gene expression higher in interval groups.
CONCLUSION: Various types of aerobic exercises with moderate-vigorous intensities gave different impact to 
mRNA liver metabolic enzyme genes.
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Introduction
The liver has an important function to maintain 
blood glucose homeostasis as well as skeletal muscle 
and adipose tissue in both fed state and fasted state. In 
the fed state, glucose is stored in the liver as glycogen, 
while in a fasted state, liver catabolism will produce 
glucose from glycolysis and gluconeogenesis [1], [2]. 
Liver metabolism requires enzymes to work properly. 
One of the most important enzymes to regulate cellular 
metabolism is AMP-activated protein kinase (AMPK). It 
is the main regulator of cellular energy and whole-body 
homeostasis that coordinates several metabolic pathways 
to adapt cellular processes to energy status [3], [4], [5].
Every physiological and pathological process 
that changes AMP/ATP ratio due to excessive use of ATP 
or lack of ATP production will activate AMPK. Activated 
AMPK switches cells metabolism from anabolic to 
catabolic state, in fed state to fasted stated, initiating 
an ATP producing pathway to restore energy balance. 
AMPK phosphorylates the transcriptional coactivator 
peroxisome proliferator-activated receptor coactivator-1α 
(PGC-1α), which controls the expression of multiple 
transcription factors to induce mitochondrial biogenesis 
[6]. Phosphorylating results in greater mitochondrial 
oxidative capacity by increasing PGC-1 expression and 
activation through PGC-1 promoter autoregulation. This 
process can lead to glucose transporter activation [7].
Several studies found that metabolic disorder 
due to mitochondrial dysfunction caused by mitochondrial 
biogenesis decreasing promote insulin resistance. Low 
hepatic PGC1-α levels are associated with insulin 
resistance. PGC-1α level determines the relative ratio 
of IRS1 and IRS2 in hepatocytes insulin resistance in 
the liver disrupt the glycogenesis process and increase 
gluconeogenesis as compensation mechanism of cell 
requirement for glucose [8], [9], [10], [11].
Exercise recently is known to improve insulin 
sensitivity, by enhancing AMPK and PGC-1α activity 
in mitochondria. A previous study shown that insulin 
receptor expression of the skeletal muscle upregulated 
after 8 weeks of exercise followed by decreasing insulin 
resistance at various type of exercise [12]. Increased 
insulin sensitivity in the muscles, thereby reducing 
insulin resistance, should be followed by metabolic 
changes in the liver. Hence, this study aimed to find out 
the expression of AMPKα1, AMPKα2, and PGC-1α in 
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type 2 diabetes mellitus (T2DM) rat model liver due to 
different types of exercise with different intensities.
Methods
Animal model
The experimental animals used in this study 
were adult male Wistar (Rattus novergicus, sp) 
which obtained from Bogor agricultural institute with 
an estimated body weight of 150–180 g. For 7 days, 
rats were given standard food as chow and drank ad 
libitum. To develop a T2DM rat model, all rats were 
given a high-fat diet on chow for 5 weeks with a 
composition of 41% fat, 41% carbohydrate, and 18% 
protein. Food weight and the cast-off weighed every 
day to determine the adequacy of the experimental 
animal calories. After 5 weeks of administration, rats 
were injected with a 30 mg/kgbw and 45 mg/kgbw of 
streptozotocin in 0.1 citrate buffer pH 4,5 at a 1-week 
interval. Examination of fasting blood sugar was carried 
out after rats were fasted for 10–12 h to ensure whether 
rat has become a T2DM model.
Intervention, blood collection, and blood 
glucose examination
T2DM rat randomly separates into five groups; 
sedentary, continuous training in moderate-intensity 
and high-intensity, slow- and fast-interval training. All 
the T2DM rats except sedentary group get used to run 
on the treadmill before protocol exercise was begun in 
15 m/min speed for 5 days. The exercise was held 3 
times a week for 2 months. Exercise protocol for T2DM 
is shown in Table 1.
Table 1: Exercise model and exercise intensity
Exercise model and intensity Speed
Moderate intensity continuous training (P1) 25 m/min, for 30 min
High-intensity continuous training (P2) 30 m/min, for 30 min
Slow interval training (P3) 25 m/min, 2 min × 10, with 1 min active rest
Fast interval training (P4) 30 s × 15, with 1 min active rest
After all, the protocol has assigned, T2DM 
fasted 10–12 h. Lateral vein at the tail was anaesthetized 
by xylocaine spray. Blood was taken from a vein 
as much as 3 ml and collected in a non-EDTA tube, 
then centrifuged in 6000 rpm. Serum from centrifuge 
product was assessed for fasting blood glucose level 
by spectrophotometer.
Tissue extraction and real-time procedure
The liver was extracted from the experimental 
animal under sedation. Sixty milligrams of liver tissue 
were inserted into RNA later and stored into the 
refrigerator −800°C. RNA from 20–30 mg tissue liver 
was isolated using the RNA easy Mini Kit (Qiagen, 
Cat. Nos .74104 dan 74106). Master mix Sybr Green 
RT-PCR two-step was used to make the working 
solution as well as gene primer of AMPK α1, AMPK α2, 
and PGC-1 α. In this study, beta-actin was chosen as 
a determinant gene. We used Rotor gene (Qiagen) to 
asses mRNA gene expression.
Gene name Primer
AMPKα1 Forward 5’-ATCCGCAGAGAGATCCAGAA-3’
Reverse 5’-CGTCGACTCTCCTTTTCGTC-3’
AMPKα2 Forward 5’-GCTGTGGATCGCCAAATTAT-3’
Reverse 5’-GCATCAGCAGAGTGGCAATA-3’
PGC-1α Forward 5’-CACCGTAAATCTGCGGGATG-3’
Reverse 5’-TATCCATTCTCAAGAGCAGCGAAAG-3’
Beta-actin Forward 5’- CCGTAAAGACCTCTATGCCAACA-3’ 
Reverse 5’-GCTAGGAGCCAGGGCAGTAATC-3’
Data analysis
The different blood glucose level pre-test and 
post-test were analyzed with independent t-test. Data 
were analyzed using SPSS program, it significant 
if p-value <0,05. Expression of mRNA each gene was 
described in a mean of cycling threshold, whenever 
up-regulate or down-regulate expression compared 
control determined with livask method.
Ethical approval
Animal handling and intervention procedure 
have been approved by the Local Ethical Committee on 
Faculty of Medicine, Universitas Sumatera Utara.
Results
From this study, we found that fasting blood 
glucose reduced after 8 weeks of exercise. Fasting blood 
glucose pre-test and post-test are shown in Figure 1.
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Figure 1: Fasting blood glucose treatment groups before and after 
exercise protocol. P1=moderate continuous training, P2=severe 
continuous training, P3=slow interval training, P4=fast interval training. 
(*)p < 0.05
Figure 1 showed that all exercise models can 
reduce blood glucose level significantly, and the highest 
reduction found in slow interval training. 
To know the expression of mRNA gene 
AMPKα1, AMPKα2 and PGC-1α, cycling threshold 
from each gene was recorded, and the expression was 
assessed by livask method.
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Table 2 shows that there was shorter 
amplification for AMPKα1 gene, and longer amplification 
for AMPKα2 gene and PGC-1α gene in the exercise 
group compared with control. It means that there 
were increasing of AMPKα1 gene expression and 
decreasing of AMPKα2 and PGC-1α gene expression 
after 8-week exercise protocol (Figure 2). Expression of 
AMPKα1, AMPKα2, and PGC-1α gene were different in 
each model of exercise with different intensity between 
moderate continuous training and severe continuous 
training, slow interval training, and fast interval training.
Discussion
This study aimed to determine the expression of 
AMPKα1, AMPK α2, and PGC-1 α gene in T2DM rat liver 
after exercise assignment. The results found that liver 
metabolic enzyme expression, that is, AMPKα1, AMPKα2, 
and PGC-1α mitochondria in each model of exercise 
which arrange every 2 days a week for 8 weeks showed 
the differences. In this study, fasting blood glucose level 
significantly declined at moderate continuous training, 
severe continuous training, and slow interval training 
even fast interval training. Decreasing in blood glucose 
as a result of exercise will affect the liver working maintain 
glucose homeostasis. AMPKα1 gene expression found 
upregulation compare sedentary group; meanwhile, 
AMPKα2 gene and PGC-1α gene expression showed 
downregulation after 8-week exercise. This is such as 
Rohling, which found that AMPK has an important rule to 
improve insulin resistance in exercise [13].
AMP-activated Protein Kinase (AMPK) 
known as mitochondrial metabolic enzyme monitoring 
systemic and cellular energy to protect the cell from 
deficit energy status. which promote gluconeogenesis 
to produce glucose [14], [5] AMPK subunit α was 
catalytic but the specific role of AMPKα1 and AMPKα2 
in metabolism still unclear. AMPKα1 is in cytoplasm and 
membrane cell [15], while AMPKα2 binds to regulatory 
β2 subunit. Foretz reported that long-term condition of 
AMPKα2 could enhance lipid oxidation, reduce fatty 
liver so insulin resistance in the liver improved [16].
Gene transcription which involves in 
lipogenesis and mitochondrial biogenesis such as 
PGC-1α modulated by AMPK [17]. Activation of AMPK 
results in the mobilization of nutrient uptake and 
catabolism for mitochondrial ATP generation to restore 
energy homeostasis impact of modulating mitochondrial 
function on nutrient metabolism in multiple tissues and 
on glucose and lipid homeostasis in diabetic animal 
models [18]. The current study showed that both AMPK 
α 2 and PGC-1α gene expression downregulated 
compared inactivity T2DM rat model. Weikert and 
Pfeifer found that there was a strong correlation 
between AMPK and PGC-1α liver mitochondria that 
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Figure 2: The expression of AMPKα1, AMPK α2, and PGC-1 α in 
various exercise models
Table 2: The expression of mRNA gene AMPKα1, AMPKα2, and PGC-1α
Gene S (∆ct) P1 (∆ct) P1/S (∆∆ct) P2 (∆ct) P2/S (∆∆ct) P3 (∆ct) P3/S (∆∆ct) P4 (∆ct) P4/S (∆∆ct)
AMPKα1 12.67 10.54 4.4 fold 11.63 2.07 fold 12.12 1.87 fold 12.19 1.4 fold
AMPKα2 7.04 7.18 0.91 fold 7.07 0.98 fold 7.21 0.89 fold 7.17 0.92 fold
PGC-1α 6.05 9.62 0.08 fold 8.98 0.06 fold 10.04 0.13 fold 9.07 0.12 fold
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have a crucial function to supply blood glucose through 
gluconeogenesis in T2DM in other cell has energy [19].
Enhancing on insulin sensitivity at the liver, 
improved insulin resistance, and liver will not produce 
gluconeogenesis. It indicate that mitochondrial 
dysfunction in the liver improved. Mitochondrial 
biogenesis regulates by PGC-1α [20], whenever 
insulin resistance has improved and fasting plasma 
glucose has gone to normal, PGC-1α as mitochondrial 
biogenesis regulator does not need to overexpress. 
That is why PGC-1α gene expression in the liver at this 
study downregulate.
Conclusion
We conclude that exercise could affect to 
metabolic enzymes gene expression in the liver of T2DM 
rat model, that is, AMPKα1, AMPKα2, and mitochondrial 
biogenesis through PGC-1α. Intensity and exercise 
model seem to influence the expression of genes.
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